Literature DB >> 2926494

Cerebral aneurysms following radiotherapy for medulloblastoma.

P J Benson1, J H Sung.   

Abstract

Three patients, two males and one female aged 21, 14, and 31 years, respectively, developed cerebral saccular aneurysms several years after undergoing radiotherapy for cerebellar medulloblastoma at 2, 5, and 14 years of age, respectively. Following surgery, all three received combined cobalt-60 irradiation and intrathecal colloidal radioactive gold (198Au) therapy, and died from rupture of the aneurysm 19, 9, and 17 years after the radiotherapy, respectively. Autopsy examination revealed no recurrence of the medulloblastoma, but widespread radiation-induced vasculopathy was found at the base of the brain and in the spinal cord, and saccular aneurysms arose from the posterior cerebral arteries at the basal cistern or choroidal fissure. The aneurysms differed from the ordinary saccular aneurysms of congenital type in their location and histological features. Their locations corresponded to the areas where intrathecally administered colloidal 198Au is likely to pool, and they originated directly from a segment of the artery rather than from a branching site as in congenital saccular aneurysms. It is, therefore, concluded that the aneurysms in these three patients were most likely radiation-induced.

Entities:  

Mesh:

Year:  1989        PMID: 2926494     DOI: 10.3171/jns.1989.70.4.0545

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

Review 1.  Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors:  P M Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

Review 2.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

3.  Endovascular glue embolization of a radiation-induced lenticulostriate artery pseudoaneurysm in a pediatric patient with optic pathway glioma: Case report and review of literature.

Authors:  Satya Narayana Patro; Daniela Iancu; Taleb Al Mansoori; Howard Lesiuk; Michael Vassilyadi
Journal:  Interv Neuroradiol       Date:  2018-05-31       Impact factor: 1.610

4.  Anterior communicating artery aneurysm following radiation therapy for optic glioma: report of a case and review of the literature.

Authors:  Kemal Yucesoy; Iman Feiz-Erfan; Robert F Spetzler; Patrick P Han; Stephen Coons
Journal:  Skull Base       Date:  2004-08

5.  Bilateral aneurysms of the cavernous internal carotid arteries following yttrium-90 implantation.

Authors:  N S McConachie; I Jacobson
Journal:  Neuroradiology       Date:  1994-11       Impact factor: 2.804

6.  Radiotherapy-related intracranial aneurysm: case presentation of a 17-year male and a meta-analysis based on individual patient data.

Authors:  Yuan-Hung Wu; Sheng-Shuan Lin; Hsin-Hung Chen; Feng-Chi Chang; Muh-Lii Liang; Tai-Tong Wong; Sang-Hue Yen; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2016-06-15       Impact factor: 1.475

7.  Vascular complications of cranial radiation.

Authors:  Daniel L Keene; Donna L Johnston; Laval Grimard; Jean Michaud; Michael Vassilyadi; Enrique Ventureyra
Journal:  Childs Nerv Syst       Date:  2006-04-11       Impact factor: 1.475

8.  Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma.

Authors:  M Bernstein; M Lumley; G Davidson; N Laperriere; P Leung
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

Review 9.  Traumatic intracranial aneurysms in childhood and adolescence. Case reports and review of the literature.

Authors:  E C Ventureyra; M J Higgins
Journal:  Childs Nerv Syst       Date:  1994-08       Impact factor: 1.475

10.  Radiation-induced cerebral aneurysm treated with endovascular coil embolization. A case report.

Authors:  Hiroaki Matsumoto; Hiroaki Minami; Ikuya Yamaura; Yasuhisa Yoshida
Journal:  Interv Neuroradiol       Date:  2014-08-28       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.